About this trial
This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Venous Leg Ulcers
Eligibility criteria
Qualifiers
Male or Female, 18 years of age or older
Subject has a medical diagnosis of venous leg ulcer or venous insufficiency with a lower extremity wound
Subject has an venous leg ulcer without infection or clinically visible exposed bone
Index wound is a minimum of 1 cm2 and a maximum of 30 cm2 at first treatment visit
Disqualifiers
Subject is unable to comply with protocol treatment
Presence of infection prior to screening.
Multiple VLUs on the same leg with < 2 cm separation from the target ulcer.
Subject has comorbid conditions that may compromise subject safety or wound healing in the opinion of the investigator, such as serious cardiovascular, renal, liver, pulmonary, autoimmune, palliative care, or inherited blood disorders
Trial design
Treatments tested in this trial
- NeoThelium FT (HCT/P 361)
Treatment groups
Sponsors and collaborators
NuScience Medical Biologics, LLC
Lead sponsor
SygNola, LLC
Collaborator